Found: 9
Select item for more details and to access through your institution.
Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 7, p. 1, doi. 10.1371/journal.pone.0200474
- By:
- Publication type:
- Article
Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11342, doi. 10.3390/ijms241411342
- By:
- Publication type:
- Article
C-Reactive Protein Levels and Risk of Cardiovascular Diseases: A Two-Sample Bidirectional Mendelian Randomization Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9129, doi. 10.3390/ijms24119129
- By:
- Publication type:
- Article
Gelatin coating enhances therapeutic cell adhesion to the infarcted myocardium via ECM binding.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277561
- By:
- Publication type:
- Article
Author Correction: Adult spiny mice (Acomys) exhibit endogenous cardiac recovery in response to myocardial infarction.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Adult spiny mice (Acomys) exhibit endogenous cardiac recovery in response to myocardial infarction.
- Published in:
- NPJ Regenerative Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41536-021-00186-4
- By:
- Publication type:
- Article
Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-73593-0
- By:
- Publication type:
- Article
Dioxin-like PCB 126 Increases Systemic Inflammation and Accelerates Atherosclerosis in Lean LDL Receptor-Deficient Mice.
- Published in:
- Toxicological Sciences, 2018, v. 162, n. 2, p. 548, doi. 10.1093/toxsci/kfx275
- By:
- Publication type:
- Article